XOMAP.PFD (XOMA Royalty) Days Sales Outstanding : 97.65 (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is XOMA Royalty Days Sales Outstanding?

XOMA Royalty's average Accounts Receivable for the three months ended in Sep. 2024 was $0.79 Mil. XOMA Royalty's Revenue for the three months ended in Sep. 2024 was $0.73 Mil. Hence, XOMA Royalty's Days Sales Outstanding for the three months ended in Sep. 2024 was 97.65.

The historical rank and industry rank for XOMA Royalty's Days Sales Outstanding or its related term are showing as below:

XOMAP.PFD' s Days Sales Outstanding Range Over the Past 10 Years
Min: 2.26 Med: 30.32 Max: 140.52
Current: 19.7

During the past 13 years, XOMA Royalty's highest Days Sales Outstanding was 140.52. The lowest was 2.26. And the median was 30.32.

XOMAP.PFD's Days Sales Outstanding is ranked better than
90.54% of 867 companies
in the Biotechnology industry
Industry Median: 70.69 vs XOMAP.PFD: 19.70

XOMA Royalty's Days Sales Outstanding increased from Sep. 2023 (51.89) to Sep. 2024 (97.65).

XOMA Royalty Days Sales Outstanding Historical Data

The historical data trend for XOMA Royalty's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XOMA Royalty Days Sales Outstanding Chart

XOMA Royalty Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

43.72

19.85

2.26

6.36

38.55

XOMA Royalty Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Days Sales Outstanding	Get a 7-Day Free Trial															51.89	26.06	30.84	4.27	97.65

Competitive Comparison of XOMA Royalty's Days Sales Outstanding

For the Biotechnology subindustry, XOMA Royalty's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

XOMA Royalty's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, XOMA Royalty's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where XOMA Royalty's Days Sales Outstanding falls into.

XOMA Royalty Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

XOMA Royalty's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.001	+	1.004)	/	2 )	/	4.758	*	365
=	0.5025					/	4.758	*	365
=	38.55

XOMA Royalty's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding (Q: Sep. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2024 )	+	Accounts Receivable (A: Sep. 2024 ))	/	count )	/	Revenue (A: Sep. 2024 )	*	Days in Period
=	( (0.526	+	1.045)	/	2 )	/	0.734	*	365 / 4
=	0.7855					/	0.734	*	365 / 4
=	97.65

XOMA Royalty (NAS:XOMAP.PFD) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

XOMA Royalty Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of XOMA Royalty's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

XOMA Royalty Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XOMA Royalty Corp (NAS:XOMAP.PFD) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

XOMAO.PFD:USA XOMA:USA 0M26:UK X0M1:Germany X0M1:Germany

Address

2200 Powell Street, Suite 310, Emeryville, CA, USA, 94608

Website

https://www.xoma.com

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.